CoChat

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis

Open access
Bromke, Mariusz A., Neubauer, Katarzyna, Kempiński, Radosław, Krzystek-Korpacka, Małgorzata · 2021 · Journal of Clinical Medicine

The DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.

Abstract

Achieving mucosal healing in patients with inflammatory bowel disease is related to a higher incidence of sustained clinical remission and it translates to lower rates of hospitalisation and surgery. The assessment methods of disease activity and response to therapy are limited and mainly rely on colonoscopy. This meta-analysis reviews the effectiveness of using faecal calprotectin as a marker for mucosal healing in inflammatory bowel disease. Two meta-analyses were conducted in parallel. The analysis on the use of faecal calprotectin in monitoring mucosal healing in colonic Crohn’s disease is based on 16 publications (17 studies). The data set for diagnostic values of faecal calprotectin in ulcerative colitis is composed of 35 original publications (total 49 studies). The DOR for the use of faecal calprotectin in Crohn’s disease is estimated to be 11.20 and the area under the sROCis 0.829. In cases of ulcerative colitis, the DOR is 14.48, while the AUC sROC is 0.858. Heterogeneity of the studies was moderatetosubstantial. Collected data show overall good sensitivity and specificity of the faecal calprotectin test, as well as a good DOR. Thus, monitoring of mucosal healing with a non-invasive faecal calprotectin test may represent an attractive option for physicians and patients with inflammatory bowel disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm10102203

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Forest plot of Diagnostic Odds Ratio calculated for the use of FC as the biomarker of mucosal healing in Crohn’s disease. Abbreviations: CI, confidence interval; OR, odds ratio. Notes: Jusué et al. compared High Range (HR) and Low Range (LR) Quantum Blue rapid kits; 1 ELISA test.
Figure 1 Forest plot of Diagnostic Odds Ratio calculated for the use of FC as the biomarker of mucosal healing in Crohn’s disease. Abbreviations: CI, confidence interval; OR, odds ratio. Notes: Jusué et al. compared High Range (HR) and Low Range (LR) Quantum Blue rapid kits; 1 ELISA test.CC BY · PubMed Central
Figure 2 Summary Receiver Operating Characteristic (SROC) curve of the application of FC in the diagnosis of mucosal healing in Crohn’s disease superimposed on Sensitivity and False Positive Rate (1-Specificity) results from 17 studies. Summary Sensitivity and summary False Positive Rate are shown as a star, with the 95% CI area circled. Abbreviations: AUC, area under the curve; Sens., sensitivity; Spec., specificity; DOR, diagnostic odds ratio, CI, confidence interval.
Figure 2 Summary Receiver Operating Characteristic (SROC) curve of the application of FC in the diagnosis of mucosal healing in Crohn’s disease superimposed on Sensitivity and False Positive Rate (1-Specificity) results from 17 studies. Summary Sensitivity and summary False Positive Rate are shown as a star, with the 95% CI area circled. Abbreviations: AUC, area under the curve; Sens., sensitivity; Spec., specificity; DOR, diagnostic odds ratio, CI, confidence interval.CC BY · PubMed Central
Figure 3 Forest plot of Diagnostic Odds Ratio calculated for the use of FC as the biomarker of mucosal healing in ulcerative colitis. Abbreviations: CI, confidence interval; OR, odds ratio. Notes: Hiraoka et al. compared ELISA and latex agglutination turbidimetric immunoassay (LATIA) kits; Lobatón et al. compared ELISA and Q-Point Of Care Test (QPOCT); Further indexed numbers mark different MH definitions: 1 MES = 0; 2 SES-CD ≤ 3; 3 MES = 0; 4 MES ≤ 1; 5 MES = 0; 6 UCEIS = 0; 7 MES = 0; 8 MES = 0; 9 MES ≤ 1; 10 MES = 0; 11 MES = 0; 12 MES = 0; 13 UCEIS ≤ 1.; 14 MES = 0; 15 MES ≤ 1; 16 MES = 0; 17 MES ≤ 1; 18 MES ≤ 1 (8 weeks of therapy); 19 MES ≤ 1 (52 weeks of therapy); 20 MES = 0 (8 weeks of therapy); 21 MES = 0 (52 weeks of therapy); 22 MES = 0, 23 UCEIS ≤ 1; 24 modified PICaSSO ≤ 3.
Figure 3 Forest plot of Diagnostic Odds Ratio calculated for the use of FC as the biomarker of mucosal healing in ulcerative colitis. Abbreviations: CI, confidence interval; OR, odds ratio. Notes: Hiraoka et al. compared ELISA and latex agglutination turbidimetric immunoassay (LATIA) kits; Lobatón et al. compared ELISA and Q-Point Of Care Test (QPOCT); Further indexed numbers mark different MH definitions: 1 MES = 0; 2 SES-CD ≤ 3; 3 MES = 0; 4 MES ≤ 1; 5 MES = 0; 6 UCEIS = 0; 7 MES = 0; 8 MES = 0; 9 MES ≤ 1; 10 MES = 0; 11 MES = 0; 12 MES = 0; 13 UCEIS ≤ 1.; 14 MES = 0; 15 MES ≤ 1; 16 MES = 0; 17 MES ≤ 1; 18 MES ≤ 1 (8 weeks of therapy); 19 MES ≤ 1 (52 weeks of therapy); 20 MES = 0 (8 weeks of therapy); 21 MES = 0 (52 weeks of therapy); 22 MES = 0, 23 UCEIS ≤ 1; 24 modified PICaSSO ≤ 3.CC BY · PubMed Central
Figure 4 Summary Receiver Operating Characteristic (sROC) curve of the application of FC in the diagnosis of mucosal healing in ulcerative colitis superimposed on Sensitivity and False Positive Rate (1-specificity) results from 49 applications. Summary Sensitivity and summary False Positive Rates are shown as a star, with the 95% CI area circled. Abbreviations: AUC, area under the curve; Sens., sensitivity; Spec. specificity; DOR, diagnostic odds ratio, CI, confidence interval.
Figure 4 Summary Receiver Operating Characteristic (sROC) curve of the application of FC in the diagnosis of mucosal healing in ulcerative colitis superimposed on Sensitivity and False Positive Rate (1-specificity) results from 49 applications. Summary Sensitivity and summary False Positive Rates are shown as a star, with the 95% CI area circled. Abbreviations: AUC, area under the curve; Sens., sensitivity; Spec. specificity; DOR, diagnostic odds ratio, CI, confidence interval.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 40

Metadata

Authors
Bromke, M. A., Neubauer, K., Kempiński, R., & Krzystek-Korpacka, M.
Affiliations
  • Wroclaw Medical University (PL)
  • Department of Biochemistry and Immunochemistry, Wroclaw Medical University, Chalubinskiego 10, 50-368 Wroclaw, Poland
Corresponding author
Bromke, Mariusz A.
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2021-05-19
Volume
10
Issue
10
Pages
2203
ISSN
2077-0383 (ISSN-L)
OpenAlex
W3161643431
Cited by
39
References
86
Citations by year
2026: 6 · 2025: 3 · 2024: 14 · 2023: 6 · 2022: 4 · 2021: 6
FWCI
1.14
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
Keywords
fecal calprotectin, mucosal healing, inflammatory bowel disease, Crohn's disease, ulcerative colitis, non-invasive biomarkers, disease activity monitoring, diagnostic accuracy, diagnostic odds ratio, sensitivity and specificity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.